Concepedia
Statistics
Publications
8
Citations
225
H-Index
Active since
2018
Affiliations
Nanjing University(Current)
China Pharmaceutical University
First Affiliated Hospital of Henan University
Chinese Academy of Sciences
Institute of Chemistry
Hao Heng is an author at Nanjing University specializing in flt3 inhibition, flt3 inhibitors, and drug discovery.
Publications per year
2018–2024
Temozolomide–Doxorubicin Conjugate as a Double Intercalating Agent and Delivery by Apoferritin for Glioblastoma Chemotherapy
Ke Du, Qiuyu Xia, Hao Heng et al. · ACS Applied Materials & Interfaces · 2020 · 45 citations
Pharmacy, Oncology, Pharmacology +17
Intrinsic Mitochondrial Reactive Oxygen Species (ROS) Activate the In Situ Synthesis of Trimethine Cyanines in Cancer Cells
Hao Heng, Gang Song, Xuetong Cai et al. · Angewandte Chemie International Edition · 2022 · 38 citations
Medicine, Cancer Biology, Oncology +17
Photoactivated In Situ Generation of Near Infrared Cyanines for Spatiotemporally Controlled Fluorescence Imaging in Living Cells
Gang Song, Hao Heng, Jiaqi Wang et al. · Angewandte Chemie International Edition · 2021 · 36 citations
Natural Sciences, Cell Biology, Chemical Biology +17
Discovery of a Potent FLT3 Inhibitor (LT-850-166) with the Capacity of Overcoming a Variety of FLT3 Mutations
Zhijie Wang, Jiongheng Cai, Jiwei Ren et al. · Journal of Medicinal Chemistry · 2021 · 33 citations · Full text
Pharmacy, Medicinal Chemistry, Oncology +13
Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation
Hao Heng, Yanle Zhi, Haoliang Yuan et al. · European Journal of Medicinal Chemistry · 2018 · 21 citations · Full text
Medicine, Medicinal Chemistry, Oncology +14
1–5 of 8